{
    "clinical_study": {
        "@rank": "80879", 
        "arm_group": [
            {
                "arm_group_label": "placebo", 
                "arm_group_type": "Placebo Comparator"
            }, 
            {
                "arm_group_label": "anakinra", 
                "arm_group_type": "Experimental"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine the safety of anakinra in patients with\n      Polyarticular-Course Juvenile Rheumatoid Arthritis, a form of rheumatoid arthritis affecting\n      children."
        }, 
        "brief_title": "Juvenile Rheumatoid Arthritis", 
        "completion_date": {
            "#text": "November 2003", 
            "@type": "Actual"
        }, 
        "condition": "Juvenile Chronic Arthritis", 
        "condition_browse": {
            "mesh_term": [
                "Arthritis", 
                "Arthritis, Rheumatoid", 
                "Arthritis, Juvenile Rheumatoid"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "-  Male or female age 2-17 yrs inclusive * Minimum weight 10 KG * Diagnosis of Chronic\n             Arthritis"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "17 Years", 
            "minimum_age": "2 Years"
        }, 
        "enrollment": {
            "#text": "86", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "May 17, 2002", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00037648", 
            "org_study_id": "990758-990779"
        }, 
        "intervention": [
            {
                "arm_group_label": "anakinra", 
                "description": "anakinra", 
                "intervention_name": "Anakinra", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "placebo", 
                "description": "placebo", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Interleukin 1 Receptor Antagonist Protein"
        }, 
        "lastchanged_date": "November 25, 2009", 
        "link": {
            "description": "AmgenTrials clinical trials website", 
            "url": "http://www.amgentrials.com"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Randomized, Multi-center, Blinded, Placebo-controlled Study With an Open-label Run-in Period to Evaluate the Efficacy, Safety, and Pharmacokinetics of Daily, Single, Subcutaneous Injections of r-metHuIL-1ra (Anakinra) in Polyarticular-Course Juvenile Rheumatoid Arthritis", 
        "overall_official": {
            "affiliation": "Amgen", 
            "last_name": "MD", 
            "role": "Study Director"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "November 2003", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "The primary outcome of the study was to evaluate the safety of anakinra", 
            "safety_issue": "No", 
            "time_frame": "28 weeks"
        }, 
        "removed_countries": {
            "country": "United States"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00037648"
        }, 
        "responsible_party": {
            "name_title": "Global Development Leader", 
            "organization": "Amgen Inc."
        }, 
        "source": "Swedish Orphan Biovitrum", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Amgen", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "July 2000", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2008"
    }, 
    "geocoordinates": {}
}